Alpha Biologix peptides: prices, COAs and vendor facts
Alpha Biologix is a research-peptide vendor that lists 70 injectable peptides, including Epitalon, SS-31 and FOXO4-DRI. Across 64 products with a market median, its prices sit 143% above the median for the same peptide and vial size; it sits above the market on Tirzepatide and Glutathione. We found no certificates for the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index. 3 listings are labelled made in USA.
What the record shows
COA coverage: None found
We found no certificates for the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index.
- Current certificates
- 0
- Tested within a year
- 0
- Labs named
- 0
- Freshest test date
- None printed
from 0 indexed documents
current certificates, by the date printed on them
named on 0 certificates
across current certificates
Price position
- Tirzepatide▲ 557%
- Glutathione▲ 410%
- Tirzepatide▲ 380%
Price history
$15/mg median
▲ 20%
Median price per mg across Alpha Biologix’s 51-70 priced listings, from Sep 29 ($12.50/mg) to Oct 12 ($15/mg) over 13 observed days. The mix of products behind the median changes as listings come and go, so this tracks the catalog as well as the prices.
Recent price changes
1 of Alpha Biologix’s tracked listings changed price in the last 30 days: 1 down, 0 up.
Price check
Listed prices at Alpha Biologix against the median price per mg for the same peptide at the same vial size, across every vendor we track. Vendors change prices without notice, so check the current listing before you order.
Below the market median on 0 of 38 comparable listings, above it on 38. Typical listing: 108% above market. Showing the 6 largest differences.
How does Alpha Biologix compare to other peptide vendors?
Alpha Biologix
International
143% above
vs market median
40
peptides
None found
in-stock products
Oct 12
Nexgen Peptides
International
At median
vs market median
60
peptides
Limited
in-stock products
Oct 12
Peptides Greyhouse
International
7% above
vs market median
63
peptides
None found
in-stock products
Oct 12
Core Peptides Direct
International
7% below
vs market median
52
peptides
None found
in-stock products
Oct 12
Alpha Biologix sits 143% above market the tracked market median on matched peptide/size rows. The catalog in this index is smaller than Nexgen Peptides's. On COA coverage, Alpha Biologix rates none found and Nexgen Peptides rates limited. Based on the certificates our crawler found; vendors may publish more than we index.
The honest comparison unit is price per mg on matched peptide/size rows. COA coverage is presence of a current indexed document, not purity-as-quality. See the Evidence Atlas and how to read a COA.
Evidence boundary: Listed prices, stock signals, and indexed COA documents are observations. They do not establish legitimacy, authenticity, safety, sterility, chain of custody, product quality, fulfillment, or suitability. No vendor is endorsed.
Popular peptides
22 of 22 carriedFull catalog (40)
Questions about Alpha Biologix
Is Alpha Biologix legit?
Pricing data cannot settle that question, and we do not test products or verify fulfillment. Here is the evidence we do hold for Alpha Biologix. We found no certificates for the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index. Read each certificate yourself, check that its lot and compound match what you are buying, and treat anything we have not recorded as unknown rather than as an answer.
Does Alpha Biologix publish COAs?
We found no certificates for the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index. We have not recorded a testing or COA page on their site. A certificate on file records what a document says; it cannot prove chain of custody or what is in the vial you receive.
How do Alpha Biologix prices compare to other vendors?
Across 64 graded products, Alpha Biologix's median price per mg sits 143.2% above the median for the same peptide at the same vial size. We track 40 products from them in total. Price per mg is the comparison unit: a cheaper vial holding less is not a cheaper product.
Product documentation
Alpha Biologix COA coverage
Across the tracked peptide products we hold for Alpha Biologix, COA coverage rates none found. The public index contains 0 documents. That rating covers the full tracked catalogue for Alpha Biologix, including products that are currently out of stock, so it can differ from the in-stock rating above. Based on the certificates our crawler found; vendors may publish more than we index.
- Product coverage
- None found
- Tested in past year
- 0
- Older records
- 0
- Most named lab
- Not reported
across the full tracked catalogue
current certificates, by the printed test date.
Printed date is over 18 months old.
No current record names a lab.
No current certificates are on file for the tracked market listings on this page.
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
These are counts of documents in our index, and a coverage rating of what our crawler found. They do not grade vendor quality, legitimacy, or safety. Printed fields can contain transcription errors. “Older record” means the reported test date is more than 18 months old.
See the testing methodology and dataset, or compare this coverage against another vendor in the vendor comparison tool.
Cite this profile
The Peptide App. Alpha Biologix peptide prices, COA coverage and vendor facts. Updated October 12, 2026. https://www.thepeptide.app/pricing/vendor/alpha-biologix
The Peptide App. (2026). Alpha Biologix peptide prices, COA coverage and vendor facts. Retrieved from https://www.thepeptide.app/pricing/vendor/alpha-biologix
Prices and certificate counts on this page were last refreshed October 12, 2026.